Logo

Whatariff.com

Global Tariffs, Categorized
🇺🇸 United States
🇪🇸 Spain
📦 Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones
🇺🇸 → 🇪🇸

United States to Spain Trade Analysis for Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones

Detailed tariff information for Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones imports

Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones Tariff Rate

HS Code:

0%
Effective 01-Jan-2023
View general trade relationship between United States and Spain

Trade Volume

Value
Approx. €120 million
Year
2022
Trend
Stable with slight growth due to demand in pharmaceutical applications.

Special Rates

Preferential Rate
0%
Applicable under the EU-US Trade and Technology Council agreements or specific free trade arrangements.

Additional Information

No additional information available.
Last updated: 1 year ago

News and Updates

Recent News
US-Spain Trade Agreement Boosts Hormone Exports
A new bilateral trade agreement between the United States and Spain has reduced tariffs on pharmaceutical products, including hormones and their derivatives under HS Code 2937. US exports of synthetic hormones to Spain saw a 12% increase in the last quarter.
2023-10-15
Impact: Positive impact on US exporters with reduced tariffs and increased market access in Spain; potential growth in trade volume for hormone-related products.
Spain Imposes Stricter Regulations on Imported Hormones
Spain has introduced new quality control measures for imported hormones and polypeptides (HS Code 2937) to ensure compliance with EU safety standards. This has caused delays in US shipments at Spanish ports.
2023-09-01
Impact: Negative short-term impact on US exporters due to delays and additional compliance costs; may affect trade flow until adjustments are made.
US Pharmaceutical Firm Expands Hormone Production for Spanish Market
A major US pharmaceutical company announced plans to increase production of synthetic prostaglandins and leukotrienes for export to Spain, citing growing demand in the Spanish healthcare sector.
2023-08-20
Impact: Positive impact on trade with potential for increased US exports to Spain; strengthens bilateral trade ties in the pharmaceutical sector.
Policy Updates
US-Spain Bilateral Tariff Reduction on Pharmaceuticals
The US and Spain finalized a tariff reduction agreement on pharmaceutical goods, including hormones and derivatives (HS Code 2937), lowering duties by 5% to promote trade and support healthcare industries.
Date: 2023-10-10
EU Updates Safety Standards for Hormone Imports
The European Union, including Spain, updated safety and labeling requirements for imported hormones and related compounds under HS Code 2937, requiring additional documentation and testing for compliance.
Date: 2023-08-30